Maternal serum placental isoferritin levels in pregnant women with abnormal uterine artery doppler velocemitry

American Journal of Perinatology

Volumn 15, Issue 11, 1998, Pages 607-612

  Maymon, R ^a,b,c   Jauniaux, E ^c   Bar, J ^a,b   Moroz, C ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Doppler velocemitry; Intrauterine growth retardation; Placental isoferritin; Preeclamptic toxemia

Indexed keywords

ISOFERRITIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL SERUM; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UTERINE ARTERY; VASCULAR DISEASE; VENOUS BLOOD;

EID: 0032466166     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994078     Document Type: Article

References (16)

1. Parhami-Seven B, Moroz C. A unique sub-unit structure of human placental ferritin identified by the use of monoclonal antibodies. Ital J Clin Pathol 1986;1:17-23
2. Matzner Y, Konijn AM, Shlomai Z, Ben Basset H. Differential effect of isolated placental isoferritin on in vitro T lymphocyte function. Br J Haematol 1985;59:443-448
3. Sirota L, Kupfer B, Moroz C. Placental isoferritin as a physiological down regulator of cellular immunoreactivity during pregnancy. Clin Exp Immunol 1989;77:255-262
4. Maymon R, Moroz C. Placental isoferritin: a new biomarker from conception to delivery. Br J Obstet Gynaecol 1996;103:301-305
5. Moroz C, Bessler H, Sirota L, Dulitzky F, Djaldetti M. Difference in the placental ferritin levels measured by a specific monoclonal antibody enzymoassay in preterm and term delivery. Clin Exp Immunol 1987;69:702-706
6. Rosen AC, Rosen HR, Huber K, Bauer K, Ausch C, Redlich K, Klein MJ, Moroz C. Correlation of placental isoferritin with birthweight and timepoint after first contraction. Gynecol Obstet Invest 1995; 139:11-14
7. Maymon R., Bahary C, Moroz C. Placental isoferritin measured by specific monoclonal antibody as a predictive marker for preterm contraction outcome. Obstet Gynecol 1989;74:597-599
8. Maymon R, Bahary C, Moroz C. Placental isoferritin: A new serum marker in toxemia of pregnancy. Am J Obstet Gynecol 1989;160:681-684
9. Rosen AC, Hafner E, Auerbach L, Rosen HR, Schuchter K, Huber K, Ausch CH, Moroz CH. Placental isoferritin in pregnancies with small for gestational age fetuses. Prenat Diagn 1996;16:641-646
10. Jauniaux E, Gulbis B, Tunkel S, Ramsay B, Campbell S, Meuris S. Maternal serum testing for α-fetoprotein and human chorionic gonadotropin in high risk pregnancies. Prenat Diagn 1996;16:1129-1135
11. Bower S, Bewley S, Campbell S. Improved prediction of pre-eclampsia by two stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 1993;82:78-83
12. Kloosterman GJ. On intrauterine growth: The significance of prenatal care. Int J Gynecol Obstet 1970; 8:895-912
13. Scott JR, DiSaia PJ, Hammono CB, Spellacy WN (eds). Hypertensive disorders of pregnancy. In: Danforth's Obstetrics and Gynecology, 7th ed. Philadelphia: J.B. Lippincott Corp; 1994: pp 351-365
14. Linnet K. A review on methodology for assessing diagnostic tests. Clin Chem 1988;34:1379-1386
15. DeWolf F, DeWolf-Peters C, Brosens I, Robertson WB. The human placental bed: Electron microscopic study of trophoblastic invasion of spiral arteries. Am J Obstet Gynecol 1980;137:58-70
16. Pijneborg R, Bland JM, Robertson WB, Brosens I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983;4:397-414